Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What’s Behind the Sharp Rise in Inspiration Healthcare Stock?

Inspiration Healthcare Group PLC(LSE:IHC) surged 11.07% on April 24, 2026, marking one of the strongest moves among small-cap healthcare stocks.

Ankur Sharma | 24 April 2026

How Strong Is Demand for Asthma Diagnostics Like NIOX?

NIOX Group PLC(LSE:NIOX) dipped 0.31% on April 24, 2026, reflecting relatively stable trading conditions in the healthcare sector.

Ankur Sharma | 24 April 2026

Is Convatec a Defensive Stock Under Pressure?

Convatec Group Plc(LSE:CTEC) has declined in today’s trading session, reflecting mixed sentiment in the healthcare and medical products sector. As a global provider of medical products and technologies focused on chronic conditions, LSE:CTEC is generally considered a defensive stock. However, the recent weakness appears …

Ankur Sharma | 24 April 2026

Why are pharma stocks like Hikma rising in today’s volatile market?

The sharp 4.3% rise in LSE:HIL – Hikma Pharmaceuticals stock on 23 April 2026 reflects a powerful mix of defensive sector rotation, strong global pharma demand, and heightened geopolitical uncertainty driving investors toward resilient healthcare names. In today’s volatile global equity markets, investors are …

Ankur Sharma | 23 April 2026

What Risks Should Investors Watch in Ondine Biomedical?

Ondine Biomedical Inc. is a Canada-based life sciences company focused on developing photodisinfection-based therapies aimed at preventing and treating infections. Its core technology uses light-activated antimicrobial agents to eliminate a broad spectrum of pathogens, including bacteria, viruses, and fungi. The company primarily targets hospital-acquired …

Ishan Mudgal | 23 April 2026

How Strong Is HemoGenyx’s CAR-T and Bispecific Pipeline?

The company's pipeline is built around two complementary programmes. The first is its CDX bispecific antibody, designed to redirect a patient's own immune cells against AML blasts by engaging a tumour-associated antigen alongside a T-cell activating arm. The second is HG-CT-1, an autologous CAR-T …

Ishan Mudgal | 23 April 2026

How Strong Is HemoGenyx’s CAR-T and Bispecific Pipeline?

The company's pipeline is built around two complementary programmes. The first is its CDX bispecific antibody, designed to redirect a patient's own immune cells against AML blasts by engaging a tumour-associated antigen alongside a T-cell activating arm. The second is HG-CT-1, an autologous CAR-T …

Ankur Sharma | 23 April 2026

Are Diagnostics Stocks Like ABDX Gaining Investor Attention Again?

Abingdon Health plc(LSE:ABDX) rose 3.51% on April 23, 2026, reflecting improved sentiment in UK healthcare diagnostics and small-cap medical technology stocks.

Ankur Sharma | 23 April 2026

Abingdon Health share price, ABDX stock analysis, UK healthcare stocks, diagnostics UK, Abingdon Health outlook

Faron Pharmaceuticals Oy(LSE:FARN) rose 2.32% on April 23, 2026, reflecting modest strength in UK and European biotech equities.

Ankur Sharma | 23 April 2026

Can Creo Medical Sustain Its Strong Growth Momentum?

Creo Medical Group Plcis a UK-based medical device company focused on developing minimally invasive surgical technologies. The company specializes in advanced energy platforms that combine microwave and radiofrequency capabilities, primarily used in endoscopic procedures. Its solutions are designed to enhance precision, reduce complications, and …

Ishan Mudgal | 23 April 2026
Support

Hi! How can we help you today?

Loading…